
Orbicular Pharmaceutical Technologies
Develops niche and complex pharmaceutical dosage forms for licensing to its global partners.
Related Content
Orbicular Pharmaceutical Technologies Pvt. Ltd. specializes in developing niche generic and specialty pharmaceutical products. The company focuses on late-stage licensing to global partners, ensuring that products meet stringent regulatory requirements worldwide. Orbicular serves pharmaceutical companies looking for high-quality, innovative solutions in complex injectables, topicals, ophthalmics, parenterals, sprays, inhalations, microspheres, nano suspensions, nano emulsions, liposomes, high-end peptides, and depot suspension injections. The business operates in the pharmaceutical industry, leveraging a partnership-led model to deliver outcomes-based solutions. Revenue is generated through licensing agreements and outsourcing partnerships. Orbicular's state-of-the-art facility in Hyderabad is equipped with sophisticated analytical tools and a dedicated scientific team, ensuring quality and efficiency in research and development. The company's commitment to quality is underscored by its ISO 9001:2008 certification and a Quality by Design approach, which integrates quality into every phase of the product lifecycle.
Keywords: niche generics, specialty pharmaceuticals, late-stage licensing, global regulatory, complex injectables, nano suspensions, liposomes, depot injections, partnership model, Hyderabad facility.